EBI-031
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBI-031, covering 2016-09-15 to 2016-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema [Phase 1]